Depreciation of Processa Pharmaceuticals, Inc. from 30 Jun 2012 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Processa Pharmaceuticals, Inc. quarterly and annual Depreciation in USD history and change rate from 30 Jun 2012 to 31 Mar 2025.
  • Processa Pharmaceuticals, Inc. Depreciation for the quarter ending 31 Mar 2025 was $301, a 117% increase year-over-year.
  • Processa Pharmaceuticals, Inc. annual Depreciation for 2024 was $782, a 252% increase from 2023.
  • Processa Pharmaceuticals, Inc. annual Depreciation for 2023 was $222.
  • Processa Pharmaceuticals, Inc. annual Depreciation for 2021 was $484, a 94% decline from 2020.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Processa Pharmaceuticals, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $301 +$162 +117% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q1 2024 $139 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q1 2021 $484 -$1,628 -77% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q1 2020 $2,112 +$1 +0.05% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q1 2019 $2,111 -$1 -0.05% 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020 2020 Q1
Q1 2018 $2,112 01 Jan 2018 31 Mar 2018 10-Q 14 May 2019 2019 Q1
Q1 2016 $41,265 $159 -$18,986 -99% 01 Jan 2016 31 Mar 2016 10-Q 04 Oct 2017 2017 Q1
Q4 2015 $60,251 $7,181 +$3,712 +107% 01 Oct 2015 31 Dec 2015 10-K 25 Sep 2017 2016 FY
Q3 2015 $56,539 $10,067 -$12,360 -55% 01 Jul 2015 30 Sep 2015 10-Q 08 Sep 2017 2016 Q3
Q2 2015 $68,899 $23,858 +$500 +2.1% 01 Apr 2015 30 Jun 2015 10-Q 30 Aug 2017 2016 Q2
Q1 2015 $68,399 $19,145 -$2,630 -12% 01 Jan 2015 31 Mar 2015 10-Q 07 Aug 2017 2016 Q1
Q4 2014 $71,029 $3,469 -$13,519 -80% 01 Oct 2014 31 Dec 2014 10-K 19 Jun 2017 2015 FY
Q3 2014 $84,548 $22,427 +$7,909 +54% 01 Jul 2014 30 Sep 2014 10-Q 01 Dec 2015 2015 Q3
Q2 2014 $76,639 $23,358 +$10,135 +77% 01 Apr 2014 30 Jun 2014 10-Q 19 Aug 2015 2015 Q2
Q1 2014 $66,504 $21,775 +$8,741 +67% 01 Jan 2014 31 Mar 2014 10-Q 15 May 2015 2015 Q1
Q4 2013 $57,763 $16,988 01 Oct 2013 31 Dec 2013 10-K 14 Apr 2015 2014 FY
Q3 2013 $14,518 +$9,843 +211% 01 Jul 2013 30 Sep 2013 10-Q 13 Nov 2014 2014 Q3
Q2 2013 $13,223 +$12,508 +1749% 01 Apr 2013 30 Jun 2013 10-Q 19 Aug 2014 2014 Q2
Q1 2013 $13,034 01 Jan 2013 31 Mar 2013 10-Q 14 May 2014 2014 Q1
Q3 2012 $4,675 01 Jul 2012 30 Sep 2012 10-Q 08 Nov 2013 2013 Q3
Q2 2012 $715 01 Apr 2012 30 Jun 2012 10-Q/A 06 Sep 2013 2013 Q2

Processa Pharmaceuticals, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $782 +$560 +252% 01 Jan 2024 31 Dec 2024 10-K 20 Mar 2025 2024 FY
2023 $222 01 Jan 2023 31 Dec 2023 10-K 20 Mar 2025 2024 FY
2021 $484 -$7,962 -94% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
2020 $8,446 +$1 +0.01% 01 Jan 2020 31 Dec 2020 10-K 30 Mar 2022 2021 FY
2019 $8,445 $0 0% 01 Jan 2019 31 Dec 2019 10-K 25 Mar 2021 2020 FY
2018 $8,445 +$6,580 +353% 01 Jan 2018 31 Dec 2018 10-K 06 Mar 2020 2019 FY
2017 $1,865 +$484 +35% 01 Jan 2017 31 Dec 2017 10-K/A 08 Apr 2019 2018 FY
2016 $1,381 -$58,870 -98% 01 Jan 2016 31 Dec 2016 10-K 16 Apr 2018 2017 FY
2015 $60,251 -$10,778 -15% 01 Jan 2015 31 Dec 2015 10-K 25 Sep 2017 2016 FY
2014 $71,029 +$13,266 +23% 01 Jan 2014 31 Dec 2014 10-K 19 Jun 2017 2015 FY
2013 $57,763 +$38,581 +201% 01 Jan 2013 31 Dec 2013 10-K 14 Apr 2015 2014 FY
2012 $19,182 01 Jan 2012 31 Dec 2012 10-K 27 Mar 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.